Overview

Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting

Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to give children with gastroenteritis with persistent vomiting flavored intravenous ondansetron orally. The investigators test the palatability of the drug and check the serum level of ondansetron at 4 hours .
Phase:
Phase 1
Details
Lead Sponsor:
Hamad Medical Corporation
Treatments:
Ondansetron